ozempic and tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL What Happens When You Switch

Decreased appetite ( R63.0 plus Y42.3) is common and contributes to the weight loss effect but should be monitored to ensure adequate nutritional intake

Medication injected directly from refrigerated storage might also intensify sensations by affecting local tissue response

The M.I.C

The most frequent AE outcomes were those that resulted in hospitalization ( n = 883, 10.72%) or other medical events ( n = 1,064, 12.91%)

*Results are from a 68-week medical study of adults with obesity (BMI 30) and adults with excess weight (BMI 27) who also had weight-related medical problems including high blood pressure or high cholesterol